UCLA researchers have received an $8.9 million, five-year federal grant to investigate potential new targets for treating ...

Ellen Relkin, attorney and co-lead counsel in the New Jersey Ozempic lawsuits on NAION vision loss, shares exclusive insight and guidelines for anyone taking a GLP-1 medication.

Jason Horek said he took Wegovy to lose a few pounds. Months later, he was diagnosed with a rare eye condition that left him with permanent vision loss in one eye, a condition researchers are studying ...

ArrivalJust as the evening clinic hours were coming to an end, a man in his seventies walked in, accompanied by his family.

A Georgia nurse practitioner says she went to bed able to see normally and woke up with much of the vision in her right eye gone. Diane Wirth, 66, had been taking the weight-loss drug ... Read more ...

British research involving almost 1,000 patients found that about a fifth encountered treatments they deemed fraudulent. The majority of patients said they'd skipped these types of "treatments," ...

Pain in one eye can be caused by dryness infection corneal problems or changes in eye pressure Ophthalmologists share the ...

Patients allege drugs including Wegovy and Mounjaro caused NAION, a rare form of optic nerve damage-and that they weren't warned of the potential risk.

Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.

Cynthia Kane, an Arkansas woman who used Ozempic from October 2022 to July 2024, was among the first to sue Novo Nordisk over ...

She was taking a GLP-1 drug to lose weight when she woke up one morning with vision loss in her right eye. Here’s what doctors say about the risk.

She was taking a GLP-1 drug to lose weight when she woke up one morning with vision loss in her right eye. “It’s been very challenging,” she says. Here’s what doctors say about the risk. Hundreds of ...